Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research

Leukemia Research

Volumn 24, Issue 11, 2000, Pages 881-911

  Drexler, Hans G ^a   Matsuo, Yoshinobu ^b   MacLeod, Roderick A F ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

Cell lines; Hodgkin; Leukemia; Lymphoma; Model system; Myeloma

Indexed keywords

BURKITT LYMPHOMA; CANCER RESEARCH; CELL CULTURE; CELL IMMORTALIZATION; CELL LINE; CHROMOSOME ABERRATION; EPSTEIN BARR VIRUS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; LEUKEMIA; LYMPHOMA; MODEL; MYCOPLASMA; POINT MUTATION; PRIORITY JOURNAL; REVIEW;

CELL CULTURE TECHNIQUES; CHROMOSOME ABERRATIONS; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA; LYMPHOMA; MODELS, BIOLOGICAL; TUMOR CELLS, CULTURED;

EID: 0033739985     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(00)00070-9     Document Type: Review

References (142)

1. Observations on the living developing nerve fiber
2. On the permanent life of tissue outside of the organism
3. The growth in vitro of single isolated tissue cells
4. Banking and strain data of cell cultures
5. Terminology associated with cell, tissue and organ culture, molecular biology and molecular genetics
6. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium
7. Cytology of Burkitt's tumour (African lymphoma)
8. Human hemapoietic cell lines: A progress report
9. Classification and biological nature of established human hematopoietic cell lines
10. Continuous tissue culture of leukocytes from human leukemic bloods by application of 'gradient' principles
11. HeLa cultures defined
12. False human hematopoietic cell lines: Cross-contaminations and misinterpretations
13. History and classification of human leukemia-lymphoma cell lines
14. Human leukemia-lymphoma cell lines: Historical perspective, state of the art and future prospects
15. Multiple myeloma: Increasing evidence for a multistep transformation process
16. Malignant hematopoietic cell lines: In vitro models for the study of multiple myeloma and plasma cell leukemia
17. Malignant hematopoietic cell lines: In vitro models for the study of natural killer cell leukemia-lymphoma cell lines
18. Lymphoma cell lines: In vitro models for the study of HHV-8 + primary effusion lymphomas (body cavity-based lymphomas)
19. Characteristics of Hodgkin's disease-derived cell lines
20. The cell origin in Hodgkin's disease: Conclusions from in vivo and in vitro studies
21. The histogenesis of the Reed-Sternberg cell and its mononuclear counterparts
22. Hodgkin's disease-derived cell lines - Conflicting clues for the origin of Hodgkin's disease?
23. Immunologic, functional and moleculargenetic properties of Hodgkin-derived cell lines
24. Immunology and cellular biology of Hodgkin's disease
25. Is the Hodgkin cell a T- or B-lymphocyte?-Recent evidence from geno- and immunophenotypic analysis and in-vitro cell lines
26. The cell of origin in Hodgkin's disease
27. Hodgkin's disease derived cell lines: A review
28. Hodgkin's disease: Analysis of cell line data
29. Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines
30. The cellular biology of the Reed-Sternberg cell
31. Malignant histiocytosis in childhood: A distinctive CD30-positive clinicopathological entity associated with a chromosomal translocation involving 5q35
32. Epstein-Barr virus and CD30 + malignant lymphomas
33. Malignant histiocytosis. Histologic, cytochemical, chromosomal, and molecular data with a nosologic discussion
34. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular onogene expression
35. Leukemia cell lines: In vitro models for the study of acute promyelocytic leukemia
36. Ph positive CML cell lines
37. Leukemia cell lines: In vitro models for the study of chronic myeloid leukemia
38. Malignant hematopoietic cell lines: In vitro models for the study of myelodysplastic syndromes
39. Establishment and characterization of human B cell precursor-leukemia cell lines
40. Human B-lymphoid cell lines
41. Human myeloid leukemia cell lines: A review
42. Induction of differentiation of human acute myelogenous leukemia cells: Therapeutic implications
43. Human acute myeloid leukemia lines: Models of leukemogenesis
44. Myeloid cell lines: Tools for studying differentiation of normal and abnormal hematopoietic cells
45. Leukemic cell lines as a paradigm for myeloid differentiation
46. Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells
47. Basophil and mast cell lineages in vitro and in vivo
48. The AML14 and AML14.3D10 cell lines: A long overdue model for the study of eosinophils and more
49. Regulation of megakaryocytopoiesis
50. Review of megakaryoblastic cell lines. Characteristic biological features of human megakaryoblastic leukaemia cell lines
51. Leukemia cell lines: In vitro models for the study of Philadelphia chromosome-positive leukemia
52. Pediatric leukemia/lymphoma with t(8;14)(q24;q11)
53. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines
54. Factor-dependent human leukemia cell lines: New models for regulation of acute non-lymphocytic leukemia cell growth and differentiation
55. Interleukins and colony stimulating factors in human myeloid leukemia cell lines
56. Quantitative cell line based bioassays for human cytokines
57. Cytokine response profiles of human myeloid factor-dependent human leukemia cell lines
58. Malignant hematopoietic cell lines as models for studies of the biology of malignant lymphoproliferative diseases
59. Human leukaemic cell lines
60. Leukemia cell lines
61. Human leukemia cell lines. Clinical and theoretical significances
62. Established leukemia cell lines: Their role in the understanding and control of leukemia proliferation
63. Hematopoietic cell lines
64. Origins and properties of hematopoietic growth factor-dependent cell lines
65. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
66. p53 Alterations in human leukemia-lymphoma cell lines: In vitro artifact or prerequisite for cell immortalization?
67. Guidelines for the characterization and publication of human malignant hematopoietic cell lines
68. Studies on human leukemia. I. Spontaneous lymphoblastoid transformation of fibroblastic bone marrow cultures derived from leukemic and non-leukemic children
69. Epstein-Barr virus and its replication
70. Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996)
71. Tumorigenicity of human hematopoietic cell lines in athymic nude mice
72. The establishment of cell lines from chronic B cell leukaemias: Evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement
73. Classification of natural killer (NK) cell and NK-like T-cell malignancies
74. Lymphoproliferative disorders of natural killer cells
75. Malignancies of natural killer (NK) cell precursor: Myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia
76. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells
77. Human T-cell leukemia virus types I and II
78. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
79. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
80. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
81. Human herpesvirus type-8 (HHV-8) in haematopoietic neoplasia
82. HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas
83. Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia
84. Growth factor requirements of childhood T-lymphoblastic leukemia: Correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro
85. Establishment of human leukemia cell lines
86. Long-term growth of malignant thymocytes in vitro
87. Proposals for the characterization and description of new human leukemia-lymphoma cell lines
88. Mycoplasma contamination of cell cultures
89. Mycoplasma contamination in human leukemia cell lines. I. Comparison of various detection methods
90. Sensitivity and specificity of five different mycoplasma detection assays
91. Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines
92. Detection of mycoplasma contamination in cell cultures by PCR analysis
93. Treatment of mycoplasma contamination in a large panel of cell cultures
94. Elimination of mycoplasma from infected leukemia cell lines
95. Treatment of mycoplasma-contaminated continuous cell lines with Mycoplasma Removal Agent (MRA)
96. Mycoplasma contamination in human leukemia cell lines. II. Elimination with various antibiotics
97. Effective treatment of mycoplasma contamination in cell lines with enrofloxazin (Baytril)
98. Cell cross-contamination in cell cultures: The silent and neglected danger
99. Widespread intraspecies cross-contamination of human tumor cell line arising at source
100. Differences in DNA fingerprints of continuous leukemia-lymphoma cell lines from different sources
101. Multiparameter approach in the identification of cross-contaminated leukemia cell lines
102. Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting
103. PCR-VNTRs in forensic science
104. DNA fingerprinting of human cell lines using PCR amplification of fragment length polymorphisms
105. Efficient DNA fingerprinting method for the identification of cross-culture contamination of cell lines
106. First searchable database for DNA profiles of human cell lines: Sequential use of fingerprint techniques for authentication
107. Cell line banks and their role in cancer research
108. Regulated genomic instability and neoplasia in the lymphoid lineage
109. Genetic instability of colorectal cancers
110. Genetic instabilities in human cancers
111. Genetic instability of cancer cells is proportional to their degree of aneuploidy
112. Emergence of genetic instability in children treated for leukemia
113. Mismatch repair defects in human carcinogenesis
114. Microsatellite instabilitity in hematological malignancies
115. Instability of dinucleotide repeats in Hodgkin's disease
116. Microsatellite instability in adult T-cell leukaemia
117. Microsatellite instability during the progression of acute myelocytic leukaemia
118. Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia
119. Microsatellite instability in lymphoid leukemia and lymphoma cell lines but not in myeloid leukemia cell lines
120. Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines
121. Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements
122. Characterization and authentication
123. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability
124. Defects in a cell cycle checkpoint may be responsible for the genomic instabiliy of cancer cells
125. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
126. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
127. How aneuploidy affects metabolic control and causes cancer
128. Early contamination of the Dami cell line by HEL
129. Microsatellite instability and frameshift mutations in BAX and transforming growth factor-β RII genes are very uncommon in acute lymphoblastic leukemia in vivo but not in cell lines
130. Characterization of the human myeloid leukemia-derived cell line GF-D8 by multiplex fluorescence in situ hybridization, subtelomeric probes, and comparative genomic hybridization
131. Karyotypic dissection of Hodgkin's disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification
132. VDJ recombination
133. Ku80: Product of the XRCC5 gene and its role in DNA repair and V(D)J recombination
134. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes
135. Hodgkin's disease
136. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
137. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
138. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction